Akzo Nobel N.V. (AKZOY)
OTC: AKZOY
· Real-Time Price · USD
22.15
0.35 (1.61%)
At close: Aug 15, 2025, 3:58 PM
22.17
0.09%
After-hours: Aug 15, 2025, 03:58 PM EDT
Akzo Nobel Income Statement
Financials in EUR. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 10.53B | 10.68B | 10.71B | 10.62B | 10.69B | 10.65B | 10.67B | 10.74B | 10.87B | 10.98B | 10.85B | 10.64B | 10.19B | 9.85B | 9.59B | 9.39B | 9.26B | 8.73B |
Cost of Revenue | 6.33B | 6.39B | 6.37B | 6.29B | 6.32B | 6.31B | 6.43B | 6.6B | 6.87B | 7.05B | 6.92B | 6.74B | 6.34B | 6B | 5.73B | 5.47B | 5.25B | 4.88B |
Gross Profit | 4.2B | 4.3B | 4.34B | 4.33B | 4.37B | 4.34B | 4.23B | 4.14B | 4B | 3.92B | 3.92B | 3.9B | 3.85B | 3.85B | 3.85B | 3.92B | 4.01B | 3.85B |
Operating Income | 797M | 852M | 921M | 987M | 1.08B | 1.09B | 1.01B | 918M | 732M | 658M | 708M | 810M | 868M | 1.05B | 1.12B | 1.16B | 1.26B | 1.08B |
Interest Income | 30M | 28M | 28M | 53M | 59M | 58M | 77M | 62.2M | 48.2M | 34.2M | 30.2M | 20M | 16M | 28M | 24M | 24M | 27M | 17.3M |
Pretax Income | 690M | 750M | 833M | 831M | 878M | 878M | 777M | 735M | 582M | 525M | 602M | 753M | 825M | 1.03B | 1.1B | 1.14B | 1.24B | 1.04B |
Net Income | 415M | 468M | 542M | 562M | 588M | 529M | 442M | 418M | 313M | 301M | 361M | 531M | 611M | 766M | 829M | 809M | 865M | 733M |
Selling & General & Admin | 3.4B | 3.44B | 3.41B | 3.35B | 3.34B | 3.29B | 3.27B | 1.58B | 1.57B | 1.58B | 1.53B | 1.59B | 1.48B | 1.36B | 1.3B | 1.25B | 1.24B | 1.2B |
Research & Development | n/a | n/a | n/a | 270M | 270M | 270M | 270M | 258M | 258M | 258M | 258M | n/a | n/a | n/a | n/a | 238M | 238M | 238M |
Other Expenses | n/a | 8M | 7M | 6M | 6M | n/a | 4M | 1.69B | 1.69B | 1.69B | 1.68B | 1.5B | 1.5B | 1.44B | 1.44B | 1.52B | 1.51B | 1.58B |
Operating Expenses | 3.4B | 3.45B | 3.42B | 3.35B | 3.3B | 3.25B | 3.23B | 3.22B | 3.27B | 3.27B | 3.21B | 3.09B | 2.98B | 2.8B | 2.74B | 2.77B | 2.75B | 2.77B |
Interest Expense | 178M | 157M | 143M | 149M | 173M | 171M | 212M | 205.7M | 170.7M | 154.7M | 124.7M | 132M | 118M | 93M | 85M | 86M | 82M | 106.63M |
Selling & Marketing Expenses | n/a | n/a | n/a | 2.94B | 2.94B | 2.94B | 2.94B | 2.31B | 2.31B | 2.31B | 2.31B | n/a | n/a | n/a | n/a | 1.92B | 1.92B | 1.92B |
Cost & Expenses | 9.73B | 9.83B | 9.79B | 9.63B | 9.62B | 9.56B | 9.66B | 9.83B | 10.13B | 10.32B | 10.14B | 9.83B | 9.32B | 8.8B | 8.47B | 8.24B | 8B | 7.66B |
Income Tax Expense | 228M | 237M | 246M | 236M | 255M | 308M | 296M | 281M | 236M | 197M | 214M | 182M | 179M | 235M | 246M | 296M | 330M | 260M |
Shares Outstanding (Basic) | 1.54B | 1.54B | 1.54B | 1.54B | 1.54B | 1.54B | 1.54B | 1.54B | 1.54B | 1.53B | 1.54B | 1.57B | 1.58B | 1.6B | 1.6B | 1.66B | 1.68B | 1.7B |
Shares Outstanding (Diluted) | 1.55B | 1.54B | 1.54B | 1.54B | 1.55B | 1.54B | 1.54B | 1.55B | 1.54B | 1.53B | 1.54B | 1.57B | 1.58B | 1.6B | 1.6B | 1.66B | 1.69B | 1.7B |
EPS (Basic) | 0.27 | 0.31 | 0.35 | 0.37 | 0.38 | 0.34 | 0.29 | 0.27 | 0.20 | 0.19 | 0.23 | 0.34 | 0.39 | 0.48 | 0.51 | 0.48 | 0.51 | 0.43 |
EPS (Diluted) | 0.27 | 0.30 | 0.35 | 0.37 | 0.38 | 0.34 | 0.29 | 0.27 | 0.20 | 0.19 | 0.23 | 0.34 | 0.39 | 0.48 | 0.51 | 0.48 | 0.51 | 0.43 |
EBITDA | 1.25B | 1.27B | 1.34B | 1.43B | 1.49B | 1.5B | 1.42B | 1.31B | 1.13B | 1.04B | 1.09B | 1.19B | 1.23B | 1.42B | 1.5B | 1.52B | 1.62B | 1.44B |
EBIT | 869M | 913M | 982M | 993M | 1.05B | 1.06B | 986M | 928M | 757M | 652M | 718M | 879M | 937M | 1.13B | 1.19B | 1.22B | 1.32B | 1.14B |
Depreciation & Amortization | 376M | 376M | 371M | 370M | 363M | 359M | 357M | 359M | 367M | 366M | 368M | 367M | 357M | 354M | 349M | 345M | 349M | 355M |